TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2015

Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.

Kristin Baird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.